On 2024-05-09, PMV Pharmaceuticals, Inc. (PMVP) announced earnings per share of $-0.30 for the fiscal quarter ending 2024-03-31, beating the average analyst estimate of $-0.35.
The next expected annoucement date for quarterly earnings is 2024-08-14, with an average estimated earnings per share of $-0.34 for the fiscal quarter ending 2024-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-09 | 2024-03-31 | $-0.35 | $-0.30 |
| 2024-02-29 | 2023-12-31 | $-0.39 | $-0.31 |
| 2023-11-09 | 2023-09-30 | $-0.45 | $-0.34 |
| 2023-08-09 | 2023-06-30 | $-0.47 | $-0.38 |
| 2023-05-10 | 2023-03-31 | $-0.48 | $-0.42 |
| 2023-03-01 | 2022-12-31 | $-0.44 | $-0.43 |
| 2022-11-08 | 2022-09-30 | $-0.42 | $-0.40 |
| 2022-08-09 | 2022-06-30 | $-0.41 | $-0.38 |
| 2022-05-10 | 2022-03-31 | $-0.42 | $-0.41 |
| 2022-03-01 | 2021-12-31 | $-0.35 | $-0.41 |
| 2021-11-12 | 2021-09-30 | $-0.31 | $-0.33 |
| 2021-08-13 | 2021-06-30 | $-0.29 | $-0.29 |
| 2021-05-14 | 2021-03-31 | $-0.26 | $-0.26 |
| 2021-03-03 | 2020-12-31 | $-1.27 | $3.53 |
| 2020-11-13 | 2020-09-30 | $-0.36 | $-1.46 |